Head Office Novartis International AG CH-4002 Basel Switzerland
+41 61 324 11 11 +41 61 324 80 01 Monday - Friday, 8:30 - 17:00, GMT+1 (Central European Time)
More information
Novartis International AG Investor Relations P.O. Box CH-4002 Basel Switzerland
+41 61 324 79 44 investor.relations@novartis.com
Global Media Relations Eric Althoff Basel, Switzerland
+41 61 324 7999 eric.althoff@novartis.com
Report a suspected side effect (also known as an adverse event) related to a Novartis Pharmaceutical drug or a Novartis Vaccine.
Reporting side effects
Under the leadership of Joseph Jimenez, the Novartis Executive Committee (ECN) is responsible for overseeing the business operations of Group companies. ECN members are chosen by the Board of Directors.
Download the Novartis organizational structure (23 KB)
Joseph JimenezChief Executive Officer of Novartis
Read biography:
Juergen Brokatzky-Geiger, Ph.D.Head of Human Resources
Kevin BuehlerDivision Head, Alcon
Felix Ehrat, Ph.D.General Counsel
David EpsteinDivision Head, Novartis Pharmaceuticals
Mark C. Fishman, M.D.President of the Novartis Institutes for BioMedical Research (NIBR)
Jeff GeorgeDivision Head, Sandoz
George Gunn, MRCVSDivision Head, Novartis Animal Health Head, Novartis Corporate Responsibility
Harry KirschChief Financial Officer of Novartis AG
Brian McNamaraDivision Head, Novartis OTC
Andrin Oswald, M.D.Division Head, Novartis Vaccines and Diagnostics
Michele GalenHead Communications
Erwin Vanhaecke, Ph.D.Head Novartis Group Quality
Back to top
Rankings and awards
Fact sheet
Associate videos
Corporate organizational structure (23 KB)
Novartis campus brochure (486 KB)
Connecting with patients brochure (512 KB)
Annual report 2012 >